Cortistain is expressed in a distinct subset of cortical interneurons by Lecea Flores de Lemus, Luis de et al.
Cortistatin Is Expressed in a Distinct Subset of
Cortical Interneurons
Luis de Lecea,1 Jose´ Antonio del Rio,3 Jose´ R. Criado,2 Soledad Alca´ntara,3 Marisela Morales,2
Patria E. Danielson,1 Steven J. Henriksen,2 Eduardo Soriano,3 and J. Gregor Sutcliffe1
Departments of 1Molecular Biology and 2Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037,
and 3Unitat de Biologia Cel.lular, Facultat de Biologia, Universitat de Barcelona, Barcelona, 08028 Spain
Cortistatin is a presumptive neuropeptide that shares 11 of its
14 amino acids with somatostatin. In contrast to somatostatin,
administration of cortistatin into the rat brain ventricles specif-
ically enhances slow wave sleep, apparently by antagonizing
the effects of acetylcholine on cortical excitability. Here we
show that preprocortistatin mRNA is expressed in a subset of
GABAergic cells in the cortex and hippocampus that partially
overlap with those containing somatostatin. A significant per-
centage of cortistatin-positive neurons is also positive for parv-
albumin. In contrast, no colocalization was found between
cortistatin and calretinin, cholecystokinin, or vasoactive intes-
tinal peptide. During development there is a transient increase
in cortistatin-expressing cells in the second postnatal week in
all cortical areas and in the dentate gyrus. A transient expres-
sion of preprocortistatin mRNA in the hilar region at P16 is
paralleled by electrophysiological changes in dentate granule
cells. Together, these observations suggest mechanisms by
which cortistatin may regulate cortical activity.
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We recently isolated a cDNA clone of the rat mRNA encoding
preprocortistatin, the putative 112 amino acid precursor of a
novel neuropeptide structurally related to somatostatin (de Lecea
et al., 1996). Cortistatin shares 11 of 14 residues with somatosta-
tin, including those that are known to be responsible for soma-
tostatin binding to its receptors (Veber et al., 1979) and the
cysteines that are likely to render the peptide cyclic. The cDNA
sequence and chromosomal localization of cortistatin and soma-
tostatin indicate clearly that they are the products of separate
genes (de Lecea et al., 1996, 1997). Synthetic cortistatin was
shown to share several biological properties with somatostatin (de
Lecea et al., 1996), but its effects on cortical electrical activity and
sleep were distinct from those found for somatostatin. Moreover,
cortistatin was shown to antagonize the effects of acetylcholine on
cortical measures of excitability, whereas somatostatin enhances
acetylcholine release and potentiates acetylcholine responses
(Mancillas et al., 1986; Araujo et al., 1990). These observations
demonstrated that cortistatin is functionally distinct from soma-
tostatin and raised the possibility that cortistatin exerts its activ-
ities via an uncharacterized cortistatin-selective receptor, al-
though other explanations of different functionalities can be
considered.
Preliminary in situ hybridization studies to determine the an-
atomical locations of the cells that produce preprocortistatin
detected scattered cells throughout the cortex and hippocampus.
The positions of these cells in relation to pyramidal cells of the
hippocampus suggested that they were inhibitory interneurons, a
hypothesis consistent with the electrophysiological findings (de
Lecea et al., 1996). The complex population of intrinsic inhibitory
GABAergic neurons in the cortex and hippocampus has been
subgrouped by its specific afferent connectivity and the presence
of calcium-binding proteins (calbindin, parvalbumin, and calreti-
nin; de Felipe, 1993; Cauli et al., 1997; Kondo et al., 1997) and
neuropeptides [cholecystokinin (CCK), Hendry and Jones (1985);
vasoactive intestinal peptide (VIP), Morrison et al. (1984); neu-
ropeptide Y (NPY) and somatostatin (SST), Hendry et al.
(1984a), Schmechel et al. (1984), Somogyi et al. (1984), and
Freund and Buzsa´ki (1996)]. Calbindin-containing cortical inter-
neurons are also positive for several neuropeptides and are
known to make somatodendritic contacts with pyramidal cells
(Gulya´s and Freund, 1996). On the other hand, parvalbumin is
expressed in a nonoverlapping set of fast-firing interneurons that
make GABAergic synapses on cell bodies and axon initial seg-
ments of projection cells (Celio, 1986; Kawaguchi and Hama,
1987; de Lecea et al., 1995). The distribution of calretinin par-
tially overlaps with calbindin and labels additional GABAergic
cells (Jacobowitz and Winsky, 1991; Miettinen et al., 1992; Ac-
sa´dy et al., 1993).
Here we show that the cortistatin-expressing cells of the
cortex and hippocampus are GABAergic and positive for cal-
bindin and parvalbumin. We examine the relationships be-
tween somatostatin- and cortistatin-containing cells and find
that in many areas they are independent populations, but in
some regions there are variable extents of coexpression. We
also analyze the appearance of cortistatin mRNA in the cere-
bral cortex and hippocampus during development and use
electrophysiological techniques in vivo to correlate functional
changes with the transient expression of cortistatin in the
dentate gyrus. These results, together with previous physiolog-
ical observations, suggest mechanisms by which cortistatin may
regulate cortical activity.
MATERIALS AND METHODS
In situ hybridization. We conducted in situ hybridization essentially as
described elsewhere (de Lecea et al., 1994) with minor modifications.
Received March 24, 1997; revised May 19, 1997; accepted May 20, 1997.
This work was supported in part by grants from the National Institute of General
Medical Sciences and Comisio´n Interministerial de Ciencia y Tecnologı´a, Spain. We
thank Allan Tobin for providing the rat GAD65 and GAD67 plasmids.
Correspondence should be addressed to Dr. J. Gregor Sutcliffe at the above
address.
Copyright © 1997 Society for Neuroscience 0270-6474/97/175868-13$05.00/0
The Journal of Neuroscience, August 1, 1997, 17(15):5868–5880
Briefly, Sprague Dawley rats at various developmental stages (P0, P5,
P10, P12, P16, P21, and adults) were anesthetized and perfused intra-
cardially with 4% paraformaldehyde (PF) in PBS, pH 7.4. Brains were
removed and post-fixed in the same fixative overnight and cryoprotected
in sucrose dissolved in 4% PF. Then brains were frozen, and sections 25
mm thick were collected in cryoprotectant solution (30% glycerol, 30%
ethylene glycol, and 0.1 M PBS). Free-floating sections were incubated in
0.1% Triton X-100 in PBS, deproteinized with 0.1N HCl for 10 min,
acetylated with acetic anhydride (0.25% in 0.1 M triethanolamine hydro-
chloride, pH 8), post-fixed for 10 min in 4% PF, and prehybridized at
55°C for 3 hr in a solution containing 63 PIPES, 10% (w/v) dextran
sulfate, 50% formamide, 53 Denhardt’s, 40 mM DTT, 100 mg/ml yeast
RNA, and 100 mg/ml denatured salmon sperm DNA. We labeled a
cortistatin riboprobe by in vitro transcription of a 128 bp fragment
(nucleotides 310–438) encoding rat cortistatin, using T3 polymerase
(Ambion, Austin, TX) and 35S-uridine 59-triphosphate (UTP) (DuPont
NEN, Boston, MA). Labeled antisense cRNA was added to the sections
(10 7 cpm/ml) and incubated overnight at 55°C. Sections were transferred
to new vials and washed with 23 SSC, 10 mM b-mercaptoethanol (b-ME)
(room temperature for 10 min), digested with RNase A (37°C for 1 hr),
and washed again with 13 SSC, 50% formamide, 5 mM b-ME (55°C for
1 hr), and 0.13 SSC plus 0.1% Sarkosyl (30 min, 68°C). Sections were
mounted on coated slides (Fisher Scientific, Houston, TX) and exposed
to x-ray film and later to I lford K5 autoradiographic emulsion for 4 weeks
at 4°C. We developed the slides with Kodak D19 and counterstained with
Richardson’s blue. A sense cRNA probe, transcribed with T7 RNA
polymerase, was included as a negative control for most hybridization
experiments.
Double-label in situ hybridization. We labeled the two isoforms of rat
glutamic acid decarboxylase (GAD 65 and GAD 67, generously provided
by Dr. Allan Tobin, University of California Los Angeles, Los Angeles,
CA) with digoxigenin (DIG; Boehringer Mannheim, Indianapolis, IN)
and T3 RNA polymerase by in vitro transcription, as described by the
manufacturer. We pretreated the tissue as described above and added
10 7 cpm/ml 35S-labeled cortistatin and 200 ng of DIG-labeled GAD65 or
GAD67. After being washed at high stringency, sections were incubated
with an alkaline phosphatase-conjugated antibody to DIG (1:5000;
Boehringer Mannheim) and developed with nitroblue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate (BCIP) alkaline phosphatase sub-
strates (Life Technologies, Gaithersburg, MD). We then mounted the
sections and dipped them in emulsion, as described above.
Combined immunohistochemistry with in situ hybridization. To detect
both protein and mRNA in the same sections, we conducted in situ
hybridization first and then incubated the sections with primary antibod-
ies for 12 hr at 4°C, as described (Alca´ntara et al., 1996). After washing
the sections with PBS, we incubated with biotinylated secondary anti-
bodies and ABC–peroxidase (Vector Laboratories, Burlingame, CA).
We used 0.5 mg/ml diaminobenzidine (filtered through 0.22 mm; Sigma,
St. Louis, MO) and 0.01% H2O2 as peroxidase substrates. Then sections
were mounted and dipped in emulsion. Calbindin-specific (1:2000),
calretinin-specific (1:2000), and parvalbumin-specific (1:3000) antibodies
were obtained from SWant (Bellinzona, Switzerland). Antisera to VIP
(1:500), CCK (1:1000), or somatostatin (1:2000) have been characterized
elsewhere (Morrison et al., 1983). The antibody to somatostatin (S328)
recognizes the N-terminal region of somatostatin-28 and therefore is
unlikely to cross-react with cortistatin.
Data analysis. Sections were examined with a Zeiss Axiophot micro-
scope (Oberkochen, Germany). The delimitation of regional and laminar
boundaries was performed according to Zilles (1985). For the quantita-
tive analysis of labeled neurons, only sections processed in parallel under
exactly the same conditions and displaying similar background levels
(,10 grains/100 mm 2) were considered. Because the autoradiographic
background levels were less than six grains per cell, neuronal somata
were considered positive when overlaid by 15 or more silver grains,
although positive neurons normally displayed .25 grains. Sections hy-
bridized with a sense riboprobe never exceeded the background thresh-
old. Two different animals were analyzed for each age. To determine the
radial distribution of cortistatin mRNA-positive cells, we harvested eight
vertical strips (250 mm wide) covering the entire cortical thickness in the
following areas: somatosensory (first parietal area, PAR1), motor (hind-
limb–forelimb, HL–FL), and visual (primary monobinocular, occipital,
OC1M-B) cortices and hippocampal CA1. The number of labeled cells in
single layers was counted and their percentage relative to the remaining
cortical laminae calculated. For quantitative analysis of double-labeled
neurons, the numbers of immunoreactive cells displaying positive and
negative hybridization in the somatosensory cortex were counted in 6–15
sections from two to three animals for each neurochemical marker.
Densities of cortistatin-expressing cells were determined by counting
positive cells in eight frames (650 3 440 mm) corresponding to the
somatosensory and visual areas of three different animals.
Northern blot. Cytoplasmic RNA from whole brain samples of Sprague
Dawley rats at various developmental stages (except E14, in which the
whole head was homogenized) was extracted as described (Schibler et al.,
1980). Two micrograms of poly(A 1) RNA were run on agarose formal-
dehyde gels, transferred to nylon membranes, and hybridized with a
32P-labeled cortistatin probe. Cyclophilin was used as a control probe for
loading and RNA integrity (Danielson et al., 1988).
Electrophysiology. Male Sprague Dawley rats (adult group: 280 –300
gm, 50 – 60 d old; P15 group: 27–31 gm, 15–17 d old) were anesthetized
with halothane (3– 4%) and placed into a stereotaxic apparatus. Hal-
othane was adjusted to 0.7– 0.9% on completion of surgery and main-
tained at that level throughout the duration of the experiment. Body
temperature was measured and maintained at 37°C 6 0.5°C by a
feedback-regulated heating pad. Evoked field potentials were recorded
by one-barrel micropipette (3.0 M NaCl filled; 6 –11 mV; 1–2 mm, i.d.)
glued to a four-barrel iontophoresis electrode (tip extending 10 mm
ahead of the multibarrel tip) stereotaxically oriented into the dentate
gyrus (coordinates: 2.5–3.5 mm posterior and 2.0 –2.5 mm lateral to
bregma; 2.4 –3.0 mm ventral from dura). Acquisition, analysis, and
processing of data on- and off-line were performed by customized
National Instruments LabVIEW software on Macintosh computers.
Square-wave constant pulses (0.2–1.4 mA; 0.15 msec duration) were
generated by a Grass PSIU6 isolation unit controlled by a MASTER
8 pulse generator. Population spikes (PS) were elicited in the dentate
gyrus by stimulation of the angular bundle of the perforant path
(coordinates: 6.0 – 8.1 mm posterior and 4.0 – 4.2 mm lateral from
bregma; 2.5–3.5 mm ventral from dura) with insulated, bipolar stain-
less steel electrodes. Paired-pulse curves were tested by administering
two stimuli with varying interstimulus intervals (10 –260 msec) at
half-maximum stimulus intensity. The PS amplitude evoked by the
second stimulus was expressed as a percentage of the first. Cortistatin
(1 mg/ml) was dissolved in saline and administered iontophoretically
through one barrel of a multibarreled micropipette with Medical
Systems (Greenvale, NY) IP-2 iontophoresis pumps and BH-2 balance
unit. We routinely used retention (backing) currents of 5–15 nA and
automated balance in the side NaCl barrel to reduce polarization
artifacts. Cortistatin was ejected by positive currents (50 –150 nA) and
retained with negative currents. Results of experimental groups from
calculations performed on the stimulus–response and paired-pulse
data were expressed as mean 6 SEM. Results were compared by
repeated measures or completely randomized design ANOVA.
RESULTS
Distribution of cortistatin-positive cells
We used in situ hybridization to analyze the expression of pre-
procortistatin mRNA in adult rat brain. Film autoradiography of
coronal sections showed a discrete and punctate pattern through-
out the cerebral cortex and hippocampus, possibly corresponding
to single neurons. Weak hybridization labeling was observed in
the striatum and olfactory bulb, but no signals could be detected
in the thalamus, midbrain, cerebellum, or spinal cord. Of note,
signals were also absent from hypothalamus, an important site of
somatostatin expression.
We examined the sections by emulsion autoradiography. The
cerebral cortex was the area of the brain that contained the most
cortistatin-positive cells. In the neocortex cortistatin mRNA-
expressing neurons were found in all cortical areas and layers,
except in layer I (Fig. 1A,B). In all cortical regions cortistatin-
positive neurons were most abundant in layers II–III and VI (Fig.
2). There were also clear differences in the number of positive
cells and intensity of hybridization in different cortical areas. The
visual /temporal cortex displayed approximately twice as many
cortistatin-positive cells as other areas, especially in the upper
layers (294 6 8 cells/mm2 in visual cortex; 162 6 6 cells/mm2 in
somatosensory cortex; Figs. 1A–C, 2).
de Lecea et al. • Preprocortistatin mRNA in Cortex J. Neurosci., August 1, 1997, 17(15):5868–5880 5869
Cortistatin-positive neurons were present in layer III of the
piriform cortex as well as in layers III–IV of the entorhinal area.
In the hippocampal region cortistatin mRNA-expressing neurons
were scattered through the subiculum and CA1 region, where they
were concentrated in the stratum oriens and to a lesser extent in
the pyramidal layer (Fig. 1D,E). Cortistatin-positive cells were
present in the CA3 region at low density (fewer than five cells per
section). In the adult, hybridization signals were virtually absent
from the hilus, but a few neurons (two to three cells per section)
could be detected in the granule cell layer (Fig. 1D,E).
Other areas of the brain also showed cortistatin hybridization,
although at lower intensity. In the olfactory bulb, granule
GABAergic neurons were heavily labeled with autoradiographic
silver grains. In the striatum a small number of positive cells
resembling cholinergic or GABAergic interneurons displayed
very low levels of hybridization. A few cells in the periventricular
Figure 1. Cortistatin expression in the adult cortex. A, Dark-field view of a coronal section of the rat visual cortex hybridized with a cortistatin
riboprobe. Very heavy labeling was observed in the deep layers, whereas in the upper layers both the number of positive cells and their cortistatin mRNA
concentration were lower. B, The bright-field image of A. C, In situ hybridization of preprocortistatin mRNA in the somatosensory cortex. Note that there
are substantially fewer cells in the upper layers, as compared with A. D, Dark-field micrograph of a coronal section across the hippocampal formation,
which includes the granule cell layer of the dentate gyrus. Some labeling was found in the CA1 field (arrows), especially in the stratum oriens (so),
although some neurons in the pyramidal cell layer (sp) and stratum radiatum (sr) also could be detected. Very few or no labeled cells were found in the
dentate gyrus (dg). E, Bright-field view of D. Scale bar, 100 mm.
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hypothalamic nucleus, which were detected only with very long
exposures of emulsion autoradiography, were positive for corti-
statin mRNA. No signals were detected in the thalamus, mesen-
cephalon, brainstem, cerebellum, or spinal cord.
Cortistatin is expressed exclusively in
GABAergic interneurons
The above pattern of localization suggested that cortistatin
mRNA might be present in a subset of GABAergic nonpyramidal
interneurons. To confirm the GABAergic nature of cortistatin-
expressing cells, we used double in situ hybridization for cortista-
tin and GAD65/GAD67 mRNAs. We labeled a rat cortistatin
riboprobe with 35S-UTP and the rat GAD65 and GAD67 probes
with DIG. In both the neocortex and hippocampus (Fig. 3A) all
cortistatin-positive cells were also positive for GAD65 or
GAD67. More cortistatin-labeled cells were positive for GAD65
(77%) than for GAD67 (40%) in all cortical layers, probably
reflecting the ratio of GAD65/67 expression in the neocortex.
These results suggest that most, if not all, cortistatin-positive cells
are GABAergic.
Cortistatin and somatostatin label different
populations of interneurons
Somatostatin also is expressed by GABAergic interneurons (Ko-
saka et al., 1988; Escla´pez and Houser, 1995). To compare the
distributions of cortistatin and somatostatin, we combined immu-
nocytochemical staining for somatostatin with in situ hybridiza-
tion for preprocortistatin. Strikingly, the two statins exhibited
similar radial patterns of distribution being concentrated in layers
II–III and VI. However, fewer than one-half of the cortistatin-
positive neurons (42%, visual cortex; 33%, somatosensory cortex)
displayed somatostatin immunoreactivity. Conversely, one-fourth
(23% in somatosensory cortex; 28% in visual cortex) of
somatostatin-immunoreactive neurons displayed cortistatin hy-
bridization signals, demonstrating that cortistatin and somatosta-
tin are expressed in different populations of neurons (Figs. 3B,
4A). There were also notable differences in the degree of colo-
calization among the cortical layers. For instance, in layer II–III
and IV most positive neurons expressed either somatostatin or
cortistatin but not both, whereas in deep cortical layers (especially
Figure 2. Camera lucida drawings showing the distribution of cortistatin mRNA in coronal sections of the cerebral cortex of adult rats at three different
rostrocaudal levels. Each dot represents three labeled cells. Cg, Cingulate cortex; Ent, entorhinal cortex; Fr, frontal cortex; FL, forelimb area; HP,
hippocampus; Oc1, occipital cortex, area 1; Oc2, occipital cortex, area 2; Par1, parietal cortex, area 1; Par2, parietal cortex, area 2; Pir, piriform cortex;
PRh, perirhinal cortex; RS, retrosplenial cortex; Te1, temporal cortex, area 1; Te3, temporal cortex, area 3; I–VI, cortical layers. Scale bar, 1 mm.
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in layer VI) as many as 44% of cortistatin-positive cells also
contained somatostatin-like immunoreactivity (Fig. 4).
In the hippocampal CA1 field 58% of cortistatin-positive cells
were also immunoreactive for somatostatin. However, cortistatin/
somatostatin-positive cells represented ;30% of the somatostatin
population (Fig. 4B). The subiculum displayed a complex mixture
of labeled populations. In contrast, only very rarely could we
detect the presence of cortistatin mRNA in the hilar region of
adult animals, which was rich in somatostatin-positive cells (Fig.
3C). These findings show that cortistatin and somatostatin are
expressed in different, although partially overlapping, populations
of cortical interneurons.
Cellular characterization of cortistatin neurons
To characterize further the types of cortical interneurons that
expressed cortistatin, we used combined in situ hybridization for
preprocortistatin mRNA with immunocytochemistry to the
calcium-binding proteins parvalbumin, calbindin, and calretinin
Figure 3. Colocalization of prepro-
cortistatin mRNA with different markers
of cortical interneurons. A, Cortistatin-
positive cells (clusters of silver grains)
overlap with digoxigenin-labeled GAD65-
positive cells (arrows). B, In the upper
layers of the neocortex, cortistatin-
positive cells ( filled arrow) do not overlap
with somatostatin-immunoreactive cells
(open arrow). C, The dentate gyrus, which
is abundant in somatostatin immunoreac-
tivity (open arrows), contains very few
cortistatin-expressing cells that are local-
ized in the granule cell layer ( filled
arrow); h, hilar region; gcl, granule
cell layer. D, A significant number of
cortistatin-positive cells was also positive
for parvalbumin immunoreactivity in the
visual cortex (double-positive cells are
marked by thin arrows). E, Cortistatin
mRNA frequently colocalized with
calbindin-immunoreactive material, es-
pecially in the deep layers of the visual
neocortex (double-positive cells are
marked by thin arrows). A cortistatin-only
positive cell is marked with a thick arrow.
F, In the hippocampus cortistatin mRNA
was present in a subset of parvalbumin-
positive interneurons (thin arrow); so,
stratum oriens; sp, stratum pyramidale.
Scale bar, 50 mm.
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Figure 4. Preprocortistatin mRNA labels a distinct population of interneu-
rons. A, Layer distribution in the somatosensory cortex of cortistatin mRNA-
positive cells, as compared with somatostatin neurons. The overlap between
somatostatin and cortistatin cells is expressed as the percentage of cortistatin
cells that are positive for somatostatin immunoreactivity and the fraction of
somatostatin-immunoreactive cells that also express cortistatin. The number of
double-positive cells is indicated to the right of each bar. B, Comparison of the
distribution of somatostatin and preprocortistatin mRNA-positive cells in the
hippocampal CA1 (so, stratum oriens; sp, stratum pyramidale) and hilar region
(hilus) of the fascia dentata. A population of cortistatin-positive cells overlaps
with parvalbumin both in the somatosensory cortex ( C) and in the hippocam-
pus (D). E, The overlap between calbindin immunoreactivity and cortistatin
mRNA-positive cells in the neocortex, as expressed by the percentage of
cortistatin cells that are positive for the calbindin antibody.
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and to two neuropeptides. Together, these proteins are known to
define several subpopulations of cortical interneurons (Freund
and Buzsa´ki, 1996). Cortistatin mRNA colocalized frequently
with parvalbumin, especially in layers II–III of the visual and
somatosensory cortices (73%; Fig. 3D) and in the pyramidal layer
of the CA1 hippocampal field (75%; Fig. 3F). Double-labeled
cortistatin/parvalbumin-positive neurons represented ;40% of
the entire population of parvalbumin-immunoreactive neurons
(Fig. 4C,D).
In the deep layers of the cortex 47% of cortistatin mRNA-
expressing neurons were labeled with calbindin antibodies,
whereas in the supragranular layers and in the hippocampus
colocalization was rare. The double-labeled slides immunore-
acted for calbindin, which labels faintly most pyramidal and
granule cells in cortical layers II–III and IV and in the hippocam-
pus, also confirmed that these principal neurons did not express
cortistatin mRNA (Fig. 3E). We rarely detected double-labeled
neurons immunoreactive for calretinin. Finally, cortical interneu-
rons immunoreactive for CCK or VIP did not express cortistatin
mRNA (data not shown). These findings show that cortistatin is
expressed in a subset of calbindin- and parvalbumin-positive
interneurons.
Developmental pattern of preprocortistatin
mRNA accumulation
We examined the pattern of accumulation of cortistatin mRNA
during development. By Northern blot a single 600 nucleotide
band, corresponding to preprocortistatin mRNA, accumulated
postnatally between P5 and P10, achieved its maximal levels by
P15, and then decayed slightly into adulthood (Fig. 5). In situ
hybridization showed cortistatin-positive cells in the lower levels
of the cerebral cortex and the stratum oriens of the hippocampus
as early as P0, the earliest time point analyzed (Figs. 5–7).
Stronger hybridization signals could be detected at this stage in
the cingulate cortex and in the induseum griseum, taenia tecta,
and subiculum (Fig. 6A,B). At P5 both the number of cortistatin
mRNA-expressing cells and the individual intensity of labeling
were increased in the neocortex, although the distribution of
labeled cells remained the same, with most positive neurons being
concentrated in infragranular layers. A conspicuous increase in
cortistatin expression was noted in the hippocampus, which now
showed many intensely labeled neurons in both the stratum oriens
and pyramidal layer (Fig. 7).
At P10–P12 the levels of autoradiographic labeling increased
further both in the neocortex and hippocampus (Figs. 5B,C, 7). Of
note, some cortical areas such as the temporal and parietal cor-
tices exhibited at these stages strong labeling in supragranular
layers II–III and IV in addition to a large number of labeled
neurons in the infragranular layers. In the P10–P12 hippocampus
the distribution of cortistatin-positive cells was similar to that at
P5, but at this later age approximately five to six positive cells per
section could be detected in the hilar region. Hippocampal
cortistatin-positive cells showed intense hybridization signals at
these ages.
At P16–P21 there was a much stronger labeling than at P12, as
judged both by the density of silver grains per cell and by the
number of positive cells in all cortical areas (Figs. 6–7). In the
neocortex a nearly uniform pattern of expression was observed,
with all cortical areas displaying a large number of positive
neurons in both the deep cortical layers and the supragranular
layers. Also, the number of cortistatin-positive cells in all cortical
areas was greater than in the adult (480 6 23 cells/mm2 in P16 vs
263 6 15 cells/mm 2 in adult rats; Fig. 6E). In the hippocampus
there were more labeled cells at P16 than in both earlier and adult
stages (68 6 7 cells/section at P16, as compared with 51 6 5.3 cells
in the adult; Fig. 6F). This was particularly evident in the hilar
region, where cortistatin-expressing cells were virtually absent in
the adult.
Electrophysiological characterization of cortistatin
actions on dentate function during development
Because the expression of cortistatin mRNA in the dentate hilar
region was significantly higher at P15 than in the adult, we
examined the effects of cortistatin on dentate function during
these developmental stages. To investigate whether the adult
disappearance of cortistatin mRNA in hilar interneurons could
be paralleled by physiological and pharmacological changes in
granule cells, we conducted electrophysiological studies in vivo to
characterize the effects of local application of cortistatin on the
excitability of granule cells and on the efficacy of local inhibitory
circuits in the dentate gyrus. Stimulation of the perforant path
evoked field potentials recorded in the granule cell layer or hilus
of the dentate gyrus, the wave forms of which consisted of a
relatively fast negative-going PS superimposed on the positive-
going field EPSP/IPSP complex. Consistent with previous reports
(Wilson, 1984; Bekenstein and Lothman, 1991), we observed that
PS amplitudes at half-maximal stimulation were significantly
lower in P15 than in adults ( p , 0.005; Fig. 8A). Iontophoretic
administration of cortistatin had no significant effect on PS am-
plitudes in the adult dentate gyrus ( p . 0.05; Fig. 8B). This
contrasts with our previous observation that cortistatin inhibits
PS amplitudes in the adult CA1 (de Lecea et al., 1996). Moreover,
cortistatin suppressed PS amplitudes in the dentate gyrus of P15
rats by at least 40% in three of five animals ( p , 0.05; Fig. 8A).
Equipotent paired orthodromic stimulation of the perforant
path in the adult dentate gyrus elicited a triphasic test/conditioning
response curve (Fig. 8C). In contrast, the early inhibitory phase of
the paired-pulse response in P15 rats was significantly longer (Fig.
8C). Statistical analyses showed that paired-pulse responses in
adult and P15 rats were significantly different at 40, 60, and 80 msec
( p , 0.05; Fig. 8C; representative recordings are shown in Fig.
8D,E). These data are consistent with previous reports by Liu et al.
(1996), suggesting that GABAergic synapses dominate the synaptic
physiology of most immature granule cells. Iontophoretic admin-
istration of cortistatin had no effect on the paired-pulse responses
elicited on either group ( p . 0.05; Fig. 8C).
DISCUSSION
We have used a combination of immunocytochemical and in situ
hybridization techniques to identify the cell types that express the
precursor of the neuropeptide cortistatin in adult and developing
rat cortex and hippocampus. We have shown that the novel
neuropeptide cortistatin is expressed in a subpopulation of cor-
tical GABAergic interneurons that comprises subsets of
calbindin- and parvalbumin-immunoreactive cortical neurons.
Preprocortistatin mRNA and somatostatin are expressed in dis-
tinct but partially overlapping populations of neurons. However,
because colchicine was not used in this study, somatostatin-
immunoreactive cells could have been under-represented. The
percentages and distribution of colocalization among preprocor-
tistatin mRNA, calbindin, and somatostatin suggest that the cells
that are double-positive for cortistatin and calbindin are also
positive for somatostatin. Cortistatin has been shown to bind to at
least some somatostatin receptors with an affinity similar to that
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Figure 5. Preprocortistatin mRNA accu-
mulation during development. A, North-
ern blot of mRNAs extracted from whole
brain at different time points during rat
development, hybridized with a cortistatin
probe. The E14 sample was obtained from
whole head. An arrow indicates the length
(as determined by interpolation with un-
shown markers) of the band that hybrid-
ized with the cortistatin cDNA probe,
consistent with that reported for prepro-
cortistatin mRNA (de Lecea et al., 1996,
1997). A cyclophilin probe was hybridized
to the same blot as a control for RNA
integrity and loading. B, Horizontal sec-
tions of an in situ hybridization to P10 and
P12 rats showing that the increase in cor-
tistatin signal is attributable to an increase
in both the number of positive cells and in
the concentration per cell.
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Figure 6. In situ hybridization of preprocortistatin
mRNA in postnatal animals. A, Film autoradiograph of
a coronal section of a P0 rat hybridized with a cortista-
tin riboprobe. Strong hybridization can be observed in
the subiculum and CA1 region. B, Dark-field in situ
hybridization of a coronal section of a P0 cortex. Very
faint neurons were detected in the deep layers (arrows).
Dark-field (C) and bright-field ( D) micrographs of a P5
temporal cortex are shown. The hybridization levels
were low to moderate and confined to the deep layers of
the neocortex. E, Bright-field image of an in situ hybrid-
ization of a P16 parietal cortex. Note the very high
levels of hybridization per cell, which are visible even at
low power. The number of positive cells at this age was
approximately three times that found in adult animals.
F, Bright-field micrograph of a coronal section through
the hippocampal formation of a P16 rat. Again, very
high levels of hybridization could be detected in the
CA1 region, especially in the stratum oriens and pyra-
midale. Also, a substantial increase in the number of
cells in the granule cell layer and hilar region was
evident at this age. dg, Dentate gyrus.
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of somatostatin itself (de Lecea et al., 1996). Thus, in some cases,
cortistatin and somatostatin may be released from different ter-
minals or they may compete for the same receptors. In addition,
a previous study in adult rats showed that cysteamine-induced
release of somatostatin potentiates the response of dentate gran-
ule cells to perforant path stimulation (Takazawa et al., 1994). In
contrast, our electrophysiological data showed that iontophoretic
administration of cortistatin had no effect on PS amplitudes in the
adult dentate gyrus. These data provide indirect evidence for a
putative cortistatin receptor. The lack of effect of cortistatin on
PS amplitudes in the adult dentate gyrus could be attributable to
a disparity in brain size and packing density of neurons in the
brains of P15 and adult rats. However, the iontophoretic currents
and the duration of the application of cortistatin in this study
were similar to the parameters used in our previous study in which
cortistatin suppressed PS amplitudes in the CA1 region of adult
rats (de Lecea et al., 1996).
The cells in which most neuropeptides are produced are
calbindin-positive (Hendry et al., 1984b; de Felipe, 1993). The
calbindin-positive population of cortical interneurons has been
considered nonoverlapping with basket and chandelier cells,
which are stained with parvalbumin antibodies. However, a recent
report (Alca´ntara et al., 1996) has determined that as many as
10% of calbindin neurons are also immunoreactive for parvalbu-
min in the adult rat neocortex. Thus, it is noteworthy that cor-
tistatin is coexpressed with parvalbumin in some cortical and
hippocampal interneurons. The extent of colocalization between
cortistatin mRNA and parvalbumin (70%) and calbindin (47%)
indicates that cortistatin mRNA is localized preferentially in
neurons that are double-positive for calbindin and parvalbumin.
Figure 7. Camera lucida drawings showing the distribution of preprocortistatin mRNA in coronal sections of the cerebral cortex at P0, P5, P10, and
P16 at equivalent rostrocaudal levels. Each dot represents three labeled cells except in the P0 drawing, in which each positive cell is represented by a
dot. CP, Cortical plate; HL, hindlimb area; HP, hippocampus; Par1, parietal cortex, area 1; Par2, parietal cortex, area 2; Pir, piriform cortex; PRh,
perirhinal cortex; RS, retrosplenial cortex; I–VI, cortical layers. Cortical areas were labeled according to Paxinos and Watson (1988). Scale bar, 1 mm.
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Hippocampal neurons that contain somatostatin or parvalbumin
have been well characterized in terms of their electrophysiologi-
cal and anatomical properties (Lacaille et al., 1987; Sik et al.,
1995; Freund and Buzsa´ki, 1996). The presence of preprocortista-
tin mRNA in a substantial portion of parvalbumin-positive fast-
firing cells suggests a possible biphasic mode of action of parval-
bumin interneurons: a fast mode that releases GABA and acts on
GABAa receptors on pre- and postsynaptic cells and a slow mode
involving cortistatin release and G-protein signaling. It is possible
that cortistatin regulates principal cells at multiple levels.
In a previous report we showed that cortistatin enhanced slow
wave sleep (SWS), whereas somatostatin does not have any effect
on SWS but increases rapid eye movement sleep. Also, in contrast
to somatostatin, cortistatin antagonizes the effects of acetylcho-
line on hippocampal and cortical activity (de Lecea et al., 1996).
Cortical somatostatin-containing cells are known to receive input
from GABAergic and cholinergic projection cells in the basal
forebrain (Freund and Meskenaite, 1992) and from serotonergic
neurons in the median raphe (Halasy et al., 1992). Because single
interneurons contact multiple pyramidal cells and can synchro-
nize pyramidal activity, this afferent specificity has been proposed
as a mechanism for tight control of the output of principal cells
(Cobb et al., 1995). Thus, it may be that cholinergic afferents
innervate preferentially cortistatin-containing cells, providing a
circuitry for sleep onset. Consistent with this hypothesis is the
fact that a substantial proportion of cortistatin-positive cells re-
sides in the deep layers throughout the cortex. Because most
afferent axons to the thalamus originate in the deep layers of the
cerebral cortex, cortistatin may be regulating the corticothalamic
interactions that originate EEG spindle activity, a type of EEG
wave that occurs at the onset of SWS (Steriade et al., 1993a).
Also, because of its anatomical distribution and electrophysiolog-
ical properties, cortistatin could be a major factor in the mainte-
nance and synchronization of the slow oscillation (,1 Hz), a
cortical rhythm that is characterized by depolarizing episodes of
pyramidal and GABAergic cells and accompanies delta activity
(Steriade et al., 1993b).
The developmental expression of preprocortistatin mRNA
shows three major features in the cerebral cortex: (1) cortical
neurons express cortistatin mRNA after the typical inside-out
gradient of cortical maturation (i.e., first in deep layers and later
in upper cortical layers) (Rakic´, 1988); (2) preprocortistatin
mRNA concentration is maximal during the second postnatal
week; and (3) at P15–P21 the number of labeled neurons was
higher than in the adult, indicating a transient expression at these
stages and subsequent downregulation. These stages also corre-
spond to the maturation of cortical function. It may be of signif-
icance that cortistatin mRNA is most abundant in the visual
cortex and that its peak of expression occurs during the second
postnatal week, coincident with eye opening. Previous studies
have pointed out that the maturation of cortical interneurons is
simultaneous with the first appearance of postsynaptic inhibitory
Figure 8. Electrophysiological characterization of cortistatin actions on dentate function during development. A, Population spike (PS) amplitudes
elicited in P15 rats (n 5 7) were significantly lower than in adult rats (n 5 6; asterisk represents significance levels of p , 0.05; ANOVA). B, Iontophoretic
administration of cortistatin significantly reduced PS amplitudes in P15 rats (n 5 5; p , 0.05) but had no effect on PS amplitudes elicited in adult rats
(n 5 6; p . 0.05). C, Stimulation of the perforant path in P15 rats was characterized by a longer period of early inhibition. Control paired-pulse (PP)
responses between P15 and adult rats were significantly different at 40, 60, and 80 msec (n 5 5; p , 0.05). Administration of cortistatin had no effect
on PP responses in either group (n 5 5/group; p . 0.05). D, Representative recordings of wave forms evoked in the dentate gyrus by perforant path
stimulation (50% maximum) from an adult rat (1) and a P15 rat (2). The marked facilitatory PP response at 80 msec recorded from the adult rat (1)
contrasts with the PP response elicited in the P15 rat (2). Calibration: 5 mV, 10 msec.
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potentials and burst-firing responses linked to NMDA receptors
(Luhmann and Prince, 1991). These changes in physiological
responses of developing neurons may be associated with the
appearance of specific NMDA receptor subunits during the sec-
ond postnatal week (Williams et al., 1993). The transient expres-
sion of preprocortistatin mRNA at late postnatal stages in cortical
development is similar to that reported for other neuropeptides
such as somatostatin or NPY (Parnavelas and Cavanagh, 1988).
Particularly interesting is the transient expression of preprocor-
tistatin mRNA in the dentate gyrus. In vivo field recordings
showed a high degree of intrinsic inhibition in the dentate of P15
rats. In these animals high-frequency perforant path stimulation
failed to produce long-term potentiation in granule cells, in
contrast with our previous reports in adult rats (Criado et al.,
1996). Also in contrast to adult rats, iontophoretic application of
cortistatin in the hilus of P15 rats significantly reduced the evoked
PS amplitudes, suggesting that cortistatin receptors may be ex-
pressed in this area and functional at this age. However, despite
this evidence for expression of preprocortistatin and a cortistatin
receptor and the electrophysiological properties of dentate gran-
ule cells, in the absence of a specific cortistatin antagonist it is not
possible to establish a causal relationship between the presence of
preprocortistatin mRNA and the depressed state of granule cells
in the second postnatal week.
Nevertheless, these considerations suggest that the develop-
mental expression of cortistatin is a reflection of major changes in
the electrical activity of a distinct subset of GABAergic cells.
GABAergic stimulation has been shown to regulate the pheno-
type of hippocampal interneurons via the action of brain-derived
neurotrophic factor (BDNF) (Marty et al., 1996). The transient
increase in preprocortistatin mRNA expression during the sec-
ond postnatal week could be attributable to increased BDNF
activity caused by GABAergic stimulation of cortical neurons. In
contrast, at later developmental stages when GABA inhibits
BDNF expression (Berninger et al., 1995), cortistatin mRNA
concentration is decreased. Thus, in addition to its synchroniza-
tion properties described in adult animals, cortistatin may be
involved in refining cortical activity, possibly modulating the
establishment of synaptic connections in the neocortex and hip-
pocampus during development.
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